2 4 Researchers have further proposed that GHK-Cu may regulate expression of genes associated with inflammation, antioxidant defence, DNA repair and tissue regeneration
These compounds act on repair, inflammation, and stress response pathways that do not fit the single-indication logic of FDA drug approval
Every protocol is reviewed and approved by our Medical Director
but declining GHK production means less signal and less repair with each passing decade
This dual-action profile not only promotes extracellular matrix remodeling and wound closure in vitro but also consistently stimulates VEGF-mediated angiogenesis in endothelial assays
IV NAD therapies are not FDA-approved , have no standardized dosing, and may cause nausea, flushing, anxiety, or tachycardia